BIOMAT Database Logo BIOMAT Database Logo

The interaction of DNA-targeted 9-aminoacridine-4-carboxamide platinum complexes with DNA in intact human cells. 2002

Mark D Temple, and Patsy Recabarren, and W David McFadyen, and R J Holmes, and W A Denny, and Vincent Murray
School of Biochemistry and Molecular Genetics, University of New South Wales, Sydney, NSW 2052, Australia.

As part of an ongoing drug development programme, this paper describes the sequence specificity and time course of DNA adduct formation for a series of novel DNA-targeted analogues of cis-diaminedichloroplatinum(II) (cisplatin) (9-aminoacridine-4-carboxamide Pt complexes) in intact HeLa cells. The sequence specificity of DNA damage caused by cisplatin and analogues in human (HeLa) cells was studied using Taq DNA polymerase and a linear amplification/polymerase stop assay. Primer extension is inhibited by a Pt-DNA adduct, and hence the sites of these lesions can be analysed on DNA sequencing gels. The repetitive alphoid DNA sequence was used as the target DNA in human cells. The 9-aminoacridine-4-carboxamide Pt complexes exhibited a markedly different sequence specificity relative to cisplatin and other analogues. The sequence specificity of the 9-aminoacridine-4-carboxamide Pt complexes is shifted away from a preference for runs of guanines. The 9-aminoacridine-4-carboxamide Pt complexes have an enhanced preference for GA dinucleotides. This is the first occasion that an altered DNA sequence specificity has been demonstrated for a cisplatin analogue in human cells. A time course of DNA damage revealed that the DNA-targeted Pt complexes, consisting of four 9-aminoacridine-4-carboxamide Pt complexes and one acridine-4-carboxamide Pt complex, damaged DNA more rapidly compared to cisplatin and non-targeted analogues. A comparison of the time taken to reach half the maximum relative intensity indicated that the DNA-targeted Pt complexes reacted approximately 4-fold faster than cisplatin and the non-targeted analogues.

UI MeSH Term Description Entries
D007364 Intercalating Agents Agents that are capable of inserting themselves between the successive bases in DNA, thus kinking, uncoiling or otherwise deforming it and therefore preventing its proper functioning. They are used in the study of DNA. Intercalating Agent,Intercalating Ligand,Intercalative Compound,Intercalator,Intercalators,Intercalating Ligands,Intercalative Compounds,Agent, Intercalating,Agents, Intercalating,Compound, Intercalative,Compounds, Intercalative,Ligand, Intercalating,Ligands, Intercalating
D009944 Organoplatinum Compounds Organic compounds which contain platinum as an integral part of the molecule. Compounds, Organoplatinum
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000609 Aminoacridines Acridines which are substituted in any position by one or more amino groups or substituted amino groups.
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

Mark D Temple, and Patsy Recabarren, and W David McFadyen, and R J Holmes, and W A Denny, and Vincent Murray
Interaction of cisplatin and DNA-targeted 9-aminoacridine platinum complexes with DNA.
May 2000, Biochemistry,
Mark D Temple, and Patsy Recabarren, and W David McFadyen, and R J Holmes, and W A Denny, and Vincent Murray
Groove selectivity in the interaction of 9-aminoacridine-4-carboxamide antitumor agents with DNA.
November 1987, FEBS letters,
Mark D Temple, and Patsy Recabarren, and W David McFadyen, and R J Holmes, and W A Denny, and Vincent Murray
The DNA binding properties of 9-aminoacridine carboxamide Pt complexes.
June 2021, Bioorganic & medicinal chemistry,
Mark D Temple, and Patsy Recabarren, and W David McFadyen, and R J Holmes, and W A Denny, and Vincent Murray
The interaction of DNA-targeted platinum phenanthridinium complexes with DNA in human cells.
January 2001, Anti-cancer drug design,
Mark D Temple, and Patsy Recabarren, and W David McFadyen, and R J Holmes, and W A Denny, and Vincent Murray
Characterising the atypical 5'-CG DNA sequence specificity of 9-aminoacridine carboxamide Pt complexes.
August 2014, Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry,
Mark D Temple, and Patsy Recabarren, and W David McFadyen, and R J Holmes, and W A Denny, and Vincent Murray
The interaction of DNA-targeted platinum phenanthridinium complexes with DNA.
September 1998, Nucleic acids research,
Mark D Temple, and Patsy Recabarren, and W David McFadyen, and R J Holmes, and W A Denny, and Vincent Murray
Substituted 9-aminoacridine-4-carboxamides tethered to platinum(II)diamine complexes: chemistry, cytotoxicity and DNA sequence selectivity.
August 2010, Journal of inorganic biochemistry,
Mark D Temple, and Patsy Recabarren, and W David McFadyen, and R J Holmes, and W A Denny, and Vincent Murray
CpG methylation increases the DNA binding of 9-aminoacridine carboxamide Pt analogues.
October 2016, Bioorganic & medicinal chemistry,
Mark D Temple, and Patsy Recabarren, and W David McFadyen, and R J Holmes, and W A Denny, and Vincent Murray
Complexes of derivatives of 1-nitro-9-aminoacridine with DNA.
January 1975, Acta biochimica Polonica,
Mark D Temple, and Patsy Recabarren, and W David McFadyen, and R J Holmes, and W A Denny, and Vincent Murray
DNA-directed aniline mustards based on 9-aminoacridine: interaction with DNA.
November 1992, Chemico-biological interactions,
Copied contents to your clipboard!